Arkansas State University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.astate.edu
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2004-05-27
- Last Posted Date
- 2015-11-23
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 668
- Registration Number
- NCT00083551
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-05-27
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 40
- Registration Number
- NCT00083538
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-05-27
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 250
- Registration Number
- NCT00083577
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Study of Combination PS-341 and Thalidomide in Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2004-05-26
- Last Posted Date
- 2010-08-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 86
- Registration Number
- NCT00083460
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2010-07-05
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 20
- Registration Number
- NCT00083408
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 83
- Registration Number
- NCT00083382
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
UARK 2003-33, Total Therapy III
- First Posted Date
- 2004-04-29
- Last Posted Date
- 2017-10-17
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 303
- Registration Number
- NCT00081939
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
An Open Protocol for the Compassionate Use of Thalidomide
- Conditions
- Multiple Myeloma
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 250
- Registration Number
- NCT00081757
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences/MIRT, Little Rock, Arkansas, United States
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-03-01
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- University of Arkansas
- Registration Number
- NCT00002652
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States